Total Laparoscopic Hysterectomy for Fibroid

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
UT Southwestern Medical Center, Dallas, TXFibroid+3 MoreTotal Laparoscopic Hysterectomy - Procedure
Eligibility
18 - 50
Female
What conditions do you have?
Select

Study Summary

This trial is testing whether there are differences in outcomes between two types of surgery for hysterectomies.

Eligible Conditions
  • Fibroid Uterus
  • Abnormal Uterine Bleeding
  • Surgery
  • Uterine Bleeding

Treatment Effectiveness

Effectiveness Progress

1 of 3

Study Objectives

1 Primary · 7 Secondary · Reporting Duration: intraoperative

after surgery to 2-weeks post-operatively
Abdomen
intraoperative
Mean difference in total operating room time
Morcellation Time
through study completion up to 6-weeks post-operatively
Mean difference from baseline in Body Image Scale Score to 6-weeks post-operatively
Pain
Mean difference from baseline in Quality of Life Score to 6-weeks post-operatively
Mean difference from baseline in Quality of Recovery Score to 2-weeks post-operatively
Rates of Post-Operative Complications

Trial Safety

Safety Progress

1 of 3

Trial Design

2 Treatment Groups

Abdominal Morcellation
1 of 2
Vaginal Morcellation
1 of 2

Experimental Treatment

46 Total Participants · 2 Treatment Groups

Primary Treatment: Total Laparoscopic Hysterectomy · No Placebo Group · N/A

Abdominal Morcellation
Procedure
Experimental Group · 1 Intervention: Total Laparoscopic Hysterectomy · Intervention Types: Procedure
Vaginal Morcellation
Procedure
Experimental Group · 1 Intervention: Total Laparoscopic Hysterectomy · Intervention Types: Procedure
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Total Laparoscopic Hysterectomy
2005
Completed Phase 3
~760

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: intraoperative

Who is running the clinical trial?

University of Texas Southwestern Medical CenterLead Sponsor
962 Previous Clinical Trials
1,108,441 Total Patients Enrolled
Kimberly A Kho, MDPrincipal InvestigatorUT Southwestern Medical Center

Eligibility Criteria

Age 18 - 50 · Female Participants · 5 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
You must be able to speak English or Spanish.
References

Frequently Asked Questions

What characteristics make a person eligible to be involved in this trial?

"Patients wishing to participate must present with vaginal bleeding and be within the age bracket of 18-50. 36 individuals are expected to enroll in this trial." - Anonymous Online Contributor

Unverified Answer

Are senior citizens eligible as participants in this research project?

"In order to join this clinical trial, all participants must be between 18 and 50 years of age. Comparatively, there are 87 trials specifically targeting patients under the age of 18 and 539 which accept people over 65." - Anonymous Online Contributor

Unverified Answer

What is the aggregate number of volunteers taking part in this clinical experiment?

"Affirmative, clinicaltrials.gov data suggests this clinical trial is enrolling participants at the present time. The investigation was initially advertised on August 1st 2020 and most recently updated on July 27th 2022; 36 individuals need to be recruited from one site in particular." - Anonymous Online Contributor

Unverified Answer

Are there vacancies available for the clinical trial?

"Affirmative. According to clinicaltrials.gov, this experiment has been open for recruitment since the 8th of January 2020 and was last updated on the 27th July 2022. It is currently searching for 36 participants from one medical facility." - Anonymous Online Contributor

Unverified Answer
Please Note: These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.